Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022
Sun, March 6, 2022
Fri, March 4, 2022
Thu, March 3, 2022

Madhu Kumar Maintained (APLS) at Strong Buy with Decreased Target to $86 on, Mar 7th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-86-on-mar-7th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Madhu Kumar of Goldman Sachs, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $102 to $86 on, Mar 7th, 2022.

Madhu has made no other calls on APLS in the last 4 months.



There are 5 other peers that have a rating on APLS. Out of the 5 peers that are also analyzing APLS, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, November 29th, 2021


These are the ratings of the 4 analyists that currently disagree with Madhu


  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $72 on, Wednesday, November 24th, 2021

Publication Contributing Sources